Cost-Effectiveness Analysis of Nirsevimab and RSVpreF Vaccine Prevention Strategies for Respiratory Syncytial Virus Disease: A Canadian Immunisation Research Network (CIRN) Study https://www.medrxiv.org/content/10.1101/2023.07.14.23292675